GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Axsome Therapeutics Inc (FRA:19X) » Definitions » Net Interest Income (for Banks)

Axsome Therapeutics (FRA:19X) Net Interest Income (for Banks)


View and export this data going back to 2017. Start your Free Trial

What is Axsome Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Axsome Therapeutics (FRA:19X) Business Description

Traded in Other Exchanges
Address
22 Cortlandt Street, 16th Floor, New York, NY, USA, 10007
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.